Management and Executive

Engineering and Development

Legal and Compliance

Human Resources

Chief Financial Officer

CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy

IgA Nephropathy Treatment Market to Hit $3.24 Billion by 2033, Fueled by ACE Inhibitors & Novel Therapies

Transcript : Travere Therapeutics, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-03-2025 01

Why Top 4% Stock Travere Therapeutics Skyrocketed To A Three-Year High

Vice President, Clinical Development (Rare Metabolic Disease)

Travere Therapeutics is a biopharmaceutical company dedicated to delivering innovation and hope to patients living with rare diseases. They are seeking a Vice President of Clinical Development to oversee clinical, scientific, and strategic aspects of their rare metabolic development programs across Phases 1-4. The role involves leading cross-functional teams, developing clinical strategies, and fostering relationships with key opinion leaders and stakeholders.

Senior Vice President Global Human Resources

VP, Global Medical Affairs

Senior Director, Global Medical Affairs

Director, Digital Innovation & Medical Excellence

Associate Director, Patient Advocacy

Sign up with Google

Sign in with Google